Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $68.8 million.

  • Bioventus' Shares Outstanding (Diluted Average) rose 548.49% to $68.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.8 million, marking a year-over-year increase of 548.49%. This contributed to the annual value of $64.5 million for FY2024, which is 303.27% up from last year.
  • According to the latest figures from Q3 2025, Bioventus' Shares Outstanding (Diluted Average) is $68.8 million, which was up 548.49% from $68.8 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Shares Outstanding (Diluted Average) ranged from a high of $68.8 million in Q3 2025 and a low of $41.8 million during Q2 2021
  • For the 5-year period, Bioventus' Shares Outstanding (Diluted Average) averaged around $59.3 million, with its median value being $62.6 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 4741.35% in 2022, then soared by 175.02% in 2023.
  • Quarter analysis of 5 years shows Bioventus' Shares Outstanding (Diluted Average) stood at $45.5 million in 2021, then surged by 35.0% to $61.4 million in 2022, then rose by 2.05% to $62.6 million in 2023, then rose by 3.03% to $64.5 million in 2024, then increased by 6.65% to $68.8 million in 2025.
  • Its last three reported values are $68.8 million in Q3 2025, $68.8 million for Q2 2025, and $66.0 million during Q1 2025.